Psychiatry organization does not endorse psychedelic treatment
Alcoholism & Drug Abuse Weekly August 5, 2022 A. Knopf
The American Psychiatric Association issued a position statement warning about the short- and long-term risks of unapproved psychedelic and empathogenic agents. The statement notes that preliminary research into using these drugs for serious conditions like treatment-resistant depression and post-traumatic stress disorder has generated growing interest in their therapeutic potential.